← Back to headlines
GSK Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share
GSK plc (GSK) has initiated a tender offer to acquire Nuvalent Inc. at a price of $124 per share, signaling a significant move in the pharmaceutical industry.
30 Jun, 13:10 — 30 Jun, 13:10
Sources
Showing 1 of 1 sources

